drugset / Trial / NCT02302456

Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery

NCT02302456

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess whether the administration of a low dose of tranexamic acid just after vaginal delivery can reduce the incidence of immediate postpartum hemorrhage, in women who receive a prophylactic administration of oxytocin.

Timeline

Start
2015-02
Primary completion
2017-01
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications